Ask the CAR T-cell Experts
Get the facts and expert advice about CAR T-cell therapy
Have questions about CAR T-cell therapy? This free webinar is designed to give you clear, trustworthy answers directly from a panel of leading CAR T experts.
When you register for this free webinar, you can submit up to three questions about CAR T-cell therapy. Our panel of CAR T experts will answer as many questions as possible during the live online webinar.
Event Details
- Date: Tuesday, October 21st, 2025
- Time: 7:00 pm Eastern
- Location: Online (Zoom/Webinar platform)
- Cost: Free
Register now and submit your questions today.
Who Should Attend
- Patients considering CAR-T therapy
- Patients currently receiving CAR-T
- Caregivers, family members, and friends
- Anyone wanting to learn more about CAR-T treatment
Why Attend?
- Get answers directly from CAR-T specialists
- Learn in plain language without medical jargon
- Feel confident making informed decisions about your care
Meet the Speakers
Dr. Diana Cirstea is a hematologist-oncologist at the Mass General Brigham Cancer Center, specializing in plasma cell disorders with a focus on T-cell redirecting therapies, including CAR T cells and T-cell engagers. Dr. Cirstea is a faculty member at Harvard Medical School and part of the Massachusetts General Hospital Multiple Myeloma Program. Her work is dedicated to advancing innovative immune-based treatments and expanding patient access to novel therapies.
Dr. Rawan Faramand is a medical oncologist at Moffit Cancer Center in Tampa, Florida, where she specializes in Blood and Marrow Transplantation and Cellular Immunotherapy.
Dr. Faramand’s clinical focus is on allogeneic stem cell transplantation for hematologic malignancies. She is particularly interested in improving outcomes for patients with acute leukemias, including acute lymphoblastic leukemias, acute myeloid leukemia, and myelodysplastic syndrome.
Dr. Jay Spiegel is an Assistant Professor at the Miami Miller School of Medicine and a hematologist in the Transplant and Cellular Therapy Division of the University of Miami Sylvester Comprehensive Cancer Center in Miami, Florida.
He is a translational researcher working to improve CAR T-cell outcomes for B-cell malignancies such as lymphoma. He has led first-in-human clinical trials of novel CAR-T therapies and investigator-initiated trials testing CAR-T in combination with targeted therapies.
